Join to View Full Profile
505 Bartram RdMoorestown, NJ 08057
Phone+1 609-706-5866
Dr. Dinubile is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale School of MedicineClass of 1978, MD
University of Pennsylvania Health SystemResidency, Internal Medicine
Certifications & Licensure
NJ State Medical License 1987 - 2025
PA State Medical License 1980 - 2000
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- A Study to Evaluate Plasma Gelsolin in Healthy Volunteers Start of enrollment: 2023 Mar 14
Roles: Study Director, Contact
Publications & Presentations
PubMed
- 6 citationsLow HDL-c levels at admission are associated with greater severity and worse clinical outcomes in patients with COVID-19 disease.Sandra Parra, Mireia Saballs, Mark DiNubile, Mireia Feliu, Simona Iftimie
Atherosclerosis Plus. 2023-06-01 - 2 citationsPlasma gelsolin levels are associated with diabetes, sex, race, and poverty.Nicole Noren Hooten, Nicolle A Mode, Edward Kowalik, Victor Omoniyi, Alan B Zonderman
Journal of Translational Medicine. 2023-03-10 - 9 citationsBlood-Borne Microparticles Are an Inflammatory Stimulus in Type 2 Diabetes Mellitus.Stephen R Thom, Veena M Bhopale, Awadhesh K Arya, Deepa Ruhela, Abid R Bhat
Immunohorizons. 2023-01-01
Press Mentions
BioAegis Therapeutics Reports Favorable Safety and Pharmacokinetic Results in Its Phase 1b/2a Dose-Escalation Study of Recombinant Human Plasma Gelsolin with Highest Doses Ever Administered to PatientsAugust 7th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
